Clinical Trial Update: Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma [Phase 3]

View source ↗

Summary

This open-label Phase 3 trial evaluated the safety and efficacy of Pulmicort Turbuhaler (budesonide) in Japanese children with asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Pulmicort Turbuhaler (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED